Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia

BACKGROUND: Waldenström macroglobulinemia (WM) is preceded by asymptomatic WM (AWM), for which the risk of progression to overt disease is not well defined. METHODS: We studied 439 patients with AWM, who were diagnosed and observed at Dana-Farber Cancer Institute between 1992 and 2014. RESULTS: Duri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Bustoros, Mark, Sklavenitis-Pistofidis, Romanos, Kapoor, Prashant, Liu, Chia-Jen, Kastritis, Efstathios, Zanwar, Saurabh, Fell, Geoffrey, Abeykoon, Jithma P., Hornburg, Kalvis, Neuse, Carl Jannes, Marinac, Catherine R., Liu, David, Soiffer, Jenny, Gavriatopoulou, Maria, Boehner, Cody, Cappuccio, Joseph M., Dumke, Henry, Reyes, Kaitlen, Soiffer, Robert J., Kyle, Robert A., Treon, Steven P., Castillo, Jorge J., Dimopoulos, Meletios A., Ansell, Stephen M., Trippa, Lorenzo, Ghobrial, Irene M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544461/
https://ncbi.nlm.nih.gov/pubmed/30990729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00394
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares